Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies

Surojit Paul; Eduardo Candelario-Jalil

doi:10.1016/j.expneurol.2020.113518

journal article Jan 01, 2021

Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies

Surojit Paul Eduardo Candelario-Jalil

Experimental Neurology Vol. 335 pp. 113518 · Elsevier BV

View at Publisher Save 10.1016/j.expneurol.2020.113518

Topics

No keywords indexed for this article. Browse by subject →

References

457

[1]

Aarts "Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions" Science (2002) 10.1126/science.1072873

[2]

Abdoulaye "A review of recent advances in neuroprotective potential of 3-N-butylphthalide and its derivatives" Biomed. Res. Int. (2016) 10.1155/2016/5012341

[3]

Albers "Stroke treatment academic industry roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies" Stroke (2011) 10.1161/strokeaha.111.618850

[4]

Aliena-Valero "Emergent uric acid treatment is synergistic with mechanical recanalization in improving stroke outcomes in male and female rats" Neuroscience (2018) 10.1016/j.neuroscience.2018.07.045

[5]

Altintas "Neuroprotective effect of ischemic preconditioning via modulating the expression of adropin and oxidative markers against transient cerebral ischemia in diabetic rats" Peptides. (2016) 10.1016/j.peptides.2016.03.011

[6]

Al-Kuraishy "Role of vinpocetine in ischemic stroke and poststroke outcomes: a critical review" Brain Circ. (2020) 10.4103/bc.bc_46_19

[7]

Amarenco "Classification of stroke subtypes" Cerebrovasc. Dis. (2009) 10.1159/000210432

[8]

Amaro "Uric acid therapy prevents early ischemic stroke progression: a tertiary analysis of the URICO-ICTUS trial (efficacy study of combined treatment with uric acid and r-tPA in acute ischemic stroke)" Stroke (2016) 10.1161/strokeaha.116.014672

[9]

Amaro "Relevance of collaterals for the success of neuroprotective therapies in acute ischemic stroke: insights from the randomized URICO-ICTUS trial" Cerebrovasc. Dis. (2019) 10.1159/000500712

[10]

Amin-Hanjani "Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice" Stroke (2001) 10.1161/01.str.32.4.980

[11]

Astrup "Thresholds in cerebral ischemia - the ischemic penumbra" Stroke (1981) 10.1161/01.str.12.6.723

[12]

Aydin "Three new players in energy regulation: preptin, adropin and irisin" Peptides (2014) 10.1016/j.peptides.2014.03.021

[13]

Aydin "Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes" Mol. Cell. Biochem. (2013) 10.1007/s11010-013-1660-4

[14]

Bai "Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema" Int. J. Stroke (2015) 10.1111/ijs.12434

[15]

Balduini "Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injury" Stroke (2001) 10.1161/hs0901.094287

[16]

Balduini "Preclinical randomized controlled multicenter trials (pRCT) in stroke research: a new and valid approach to improve translation?" Ann. Transl. Med. (2016) 10.21037/atm.2016.12.41

[17]

Ballarin "Discovery and development of NA-1 for the treatment of acute ischemic stroke" Acta Pharmacol. Sin. (2018) 10.1038/aps.2018.5

[18]

Bamford "Classification and natural history of clinically identifiable subtypes of cerebral infarction" Lancet (1991) 10.1016/0140-6736(91)93206-o

[19]

Banerjee "MicroRNA let-7c regulates macrophage polarization" J. Immunol. (2013) 10.4049/jimmunol.1202496

[20]

Banjara "Sterile neuroinflammation and strategies for therapeutic intervention" Int. J. Inflamm. (2017)

[21]

Banno "The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia" Neuropharmacology (2005) 10.1016/j.neuropharm.2004.10.002

[22]

Becker "Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats" Stroke (2001) 10.1161/01.str.32.1.206

[23]

Bedi "Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury" Stem Cells Transl. Med. (2013) 10.5966/sctm.2013-0100

[24]

van Beek "Ginkgolides and bilobalide: their physical, chromatographic and spectroscopic properties" Bioorg. Med. Chem. (2005) 10.1016/j.bmc.2005.05.056

[25]

Benjamin "Heart disease and stroke statistics-2019 update: A report from the American Heart Association" Circulation (2019) 10.1161/cir.0000000000000659

[26]

Bereczki "Vinpocetine for acute ischaemic stroke" Cochrane Database Syst. Rev. (2008)

[27]

Berger "Verapamil: failure of metabolic amelioration following global forebrain ischemia in the rat" Stroke (1984) 10.1161/01.str.15.6.1029

[28]

Berger "Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases" Br. J. Pharmacol. (2018) 10.1111/bph.13748

[29]

Bergson "Verapamil block of T-type calcium channels" Mol. Pharmacol. (2011) 10.1124/mol.110.069492

[30]

Boehme "Stroke risk factors, genetics, and prevention" Circ. Res. (2017) 10.1161/circresaha.116.308398

[31]

Boulanger "Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase" J. Neurosci. (1995) 10.1523/jneurosci.15-02-01532.1995

[32]

Braeuninger "Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems" Exp. Transl. Stroke Med. (2009) 10.1186/2040-7378-1-8

[33]

Bratane "Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor" Stroke (2011) 10.1161/strokeaha.111.618801

[34]

Briyal "Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats" Brain Res. (2012) 10.1016/j.brainres.2011.10.026

[35]

Bult "STEP: a family of brain-enriched PTPs. Alternative splicing produces transmembrane, cytosolic and truncated isoforms" Eur. J. Cell Biol. (1997)

[36]

Busch "Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury" J. Neurosci. (2011) 10.1523/jneurosci.3566-10.2011

[37]

Calin "MiR-15a and miR-16-1 cluster functions in human leukemia" Proc. Natl. Acad. Sci. U. S. A. (2008) 10.1073/pnas.0800121105

[38]

Cekanaviciute "Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice" Glia (2014) 10.1002/glia.22675

[39]

Chamorro "Yin and yang of uric acid in patients with stroke" Stroke (2004) 10.1161/01.str.0000107762.79571.7d

[40]

Chamorro "Uric acid administration for neuroprotection in patients with acute brain ischemia" Med. Hypotheses (2004) 10.1016/s0306-9877(03)00324-4

[41]

Chamorro "The immunology of acute stroke" Nat. Rev. Neurol. (2012) 10.1038/nrneurol.2012.98

[42]

Chamorro "Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial" Lancet Neurol. (2014) 10.1016/s1474-4422(14)70054-7

[43]

Chamorro "Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation" Lancet Neurol. (2016) 10.1016/s1474-4422(16)00114-9

[44]

Chamorro "Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy" Int. J. Stroke (2017) 10.1177/1747493016684354

[45]

Chan "Treatment with low dose fasudil for acute ischemic stroke in chronic hypertension" J. Cereb. Blood Flow Metab. (2017) 10.1177/0271678x17718665

[46]

Chao "Kallikrein-kinin in stroke, cardiovascular and renal disease" Exp. Physiol. (2005) 10.1113/expphysiol.2004.028464

[47]

Chao "Experimental therapy with tissue kallikrein against cerebral ischemia" Front. Biosci. (2006) 10.2741/1886

[48]

Chau, R., 2005. Methods and use of motoneuronotrophic factors, US Patent # US6841531B2.

[49]

Chau, R., Ko, P., 2007. MNTF Peptides and Compositions and methods of use, US Patent # US7183373B2.

[50]

Chen "Ischemic stroke in the elderly: an overview of evidence" Nat. Rev. Neurol. (2010) 10.1038/nrneurol.2010.36

Showing 50 of 457 references

Cited By

645

Study on the expression changes and clinical significance of ICAM-1, MMP-9, and Gal-3 in patients with ischemic stroke

Yinyan Su, Jirong Li · 2026

European Journal of Medical Researc...

TAK-242 alleviates neuroinflammation and poststroke cognitive impairment by targeting the TLR4/SYK/NF-κB pathway in a cerebral ischemia/reperfusion rat model

Qimei Yun, Zezhou Xu · 2026

European Journal of Pharmacology

Cerebrolysin as an adjuvant therapy after mechanical thrombectomy in large vessel occlusion cardioembolic stroke: a propensity score matching analysis

Ahmed Elbassiouny, Mohamed S. A. Shehata · 2025

Frontiers in Neurology

Evaluating the diagnostic accuracy of AI in ischemic and hemorrhagic stroke: A comprehensive meta-analysis

Neeraj Gul, Yumna Fatima · 2025

The Neuroradiology Journal

Mechanistic insights of neuronal death and neuroprotective therapeutic approaches in stroke

Chun Li, Yuping Luo · 2025

Neural Regeneration Research

Investigation of Anti‐Apoptotic Effects and Mechanisms of Astragaloside IV in a Rat Model of Cerebral Ischemia–Reperfusion Injury

Li Yu, Weifeng Jin · 2025

CNS Neuroscience & Therapeutics

SMP30 alleviates cerebral ischemia/reperfusion-induced neuronal injury by inhibiting HDAC4/PSD-95 to preserve mitochondrial function

Runfeng Chen, Lei Qian · 2024

Journal of Neuropathology and Exper...

Blueberry extract for the treatment of ischaemic stroke through regulating the gut microbiota and kynurenine metabolism

Raoqiong Wang, Guangrui Huang · 2024

Phytotherapy Research

Circulating lncRNA SNHG5 in Cerebral Ischemic Stroke Patients and Its Relationship with Cell Apoptosis and Inflammatory Response

Hongwen Xiao, Yan Huang · 2024

Neurochemical Journal

Gastrodin against oxidative stress-inflammation crosstalk via inhibiting mtDNA/TLR9 and JAK2/STAT3 signaling to ameliorate ischemic stroke injury

Menglian Zhang, Yaowen Zhang · 2024

International Immunopharmacology

Updates of the role of B-cells in ischemic stroke

Silin Wu, Sidra Tabassum · 2024

Frontiers in Cellular Neuroscience

Neuronal cathepsin S increases neuroinflammation and causes cognitive decline via CX3CL1‐CX3CR1 axis and JAK2‐STAT3 pathway in aging and Alzheimer's disease

Pei‐Pei Liu, Xiao‐Hui Liu · 2024

Aging Cell

Shikonin attenuates cerebral ischemia/reperfusion injury via inhibiting NOD2/RIP2/NF-κB-mediated microglia polarization and neuroinflammation

Ya Yang, Yuxiang Fei · 2024

Journal of Stroke and Cerebrovascul...

Targeting pyroptosis to treat ischemic stroke: From molecular pathways to treatment strategy

Lina Li, Chonglin Shi · 2024

International Immunopharmacology

Prolonged myelin deficits contribute to neuron loss and functional impairments after ischaemic stroke

Yong-Jie Cheng, Fei Wang · 2024

Brain

EHMT2 affects microglia polarization and aggravates neuronal damage and inflammatory response via regulating HMOX1

Huaitao Yang, Zhifang Chen · 2023

Translational Neuroscience

Predictive Value of Machine Learning Models in Postoperative Mortality of Older Adults Patients with Hip Fracture: A Systematic Review and Meta-analysis

Fan Liu, Chao Liu · 2023

Archives of Gerontology and Geriatr...

Gabapentinoids for the treatment of stroke

Ying Zhang, Chenyu Zhang · 2023

Neural Regeneration Research

Oxidative stress in the pathogenesis of stroke and its correction

M.Yu. Martynov, M.V. Zhuravleva · 2023

Zhurnal nevrologii i psikhiatrii im...

The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review

Jinsong Zeng, Tingting Bao · 2023

Frontiers in Immunology

Metrics

645

Citations

457

References

Details

Published: Jan 01, 2021
Vol/Issue: 335
Pages: 113518
License: View

Authors

S

Surojit Paul

E

Eduardo Candelario-Jalil

Funding

National Institutes of Health Award: R01 NS059962

National Institute of Neurological Disorders and Stroke Award: RFA-NS-18-034

Cite This Article

Surojit Paul, Eduardo Candelario-Jalil (2021). Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies. Experimental Neurology, 335, 113518. https://doi.org/10.1016/j.expneurol.2020.113518

Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies

You May Also Like